// App-Quantinova.ai

e19121 : Prognostic value of programmed death-ligand 1 in solid tumors: A meta-analysis.

Researchers

Presenter

  • Jordan L Scott

Principal Investigators

  • Michelle Nadler

  • Alexandra Desnoyers

  • Fahad Almugbel

  • Rouhi Fazelzad

  • Eitan Amir

  • Ramy Saleh

Medical Centers

  • University of Toronto, Toronto, ON, Canada

  • McMaster University, Ancaster,Canada

  • Centre hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada

  • Princess Margaret - University Health Network, Toronto, ON, CA

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A